Literature DB >> 8988031

Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland.

J M Geurts1, E F Schoenmakers, E Röijer, G Stenman, W J Van de Ven.   

Abstract

The developmentally regulated HMGIC gene, which encodes an architectural transcription factor, has recently been linked to the pathogenesis of benign solid tumors with chromosome aberrations involving 12q13-15. Among these tumors are pleomorphic adenoma of the salivary glands, lipoma, uterine leiomyoma, hamartomas of the breast and lung, fibroadenoma of the breast, angiomyxoma, and endometrial polyps. For most tumor types, however, the translocation partners are variable. At present, no translocation partner genes of HMGIC are known for pleomorphic adenomas. Here, we report that in a primary pleomorphic adenoma of the parotid gland, the FHIT gene, which spans the chromosome 3p14.2 fragile site FRA3B, and is frequently disrupted in tumors, acts as a fusion partner of HMGIC. In addition to normal HMGIC and FHIT transcripts, an HMGIC/FHIT hybrid transcript as well as its reciprocal counterpart, FHIT/HMGIC, were found to be expressed by reverse transcription-PCR. The results establish the concurrent disruption of two tumor-associated genes in a benign tumor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8988031

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.

Authors:  Nora Katabi; Ronald Ghossein; Alan Ho; Snjezana Dogan; Lei Zhang; Yun-Shao Sung; Cristina R Antonescu
Journal:  Hum Pathol       Date:  2014-09-07       Impact factor: 3.466

2.  Cloning and molecular characterization of part of a new gene fused to HMGIC in mesenchymal tumors.

Authors:  B Kazmierczak; P Dal Cin; S Wanschura; S Bartnitzke; H Van den Berghe; J Bullerdiek
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

3.  A subset of cutaneous and soft tissue mixed tumors are genetically linked to their salivary gland counterpart.

Authors:  Armita Bahrami; James D Dalton; Jeffrey F Krane; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2011-10-28       Impact factor: 5.006

4.  PLAG1 expression in cutaneous mixed tumors: an immunohistochemical and molecular genetic study.

Authors:  Atsuji Matsuyama; Masanori Hisaoka; Hiroshi Hashimoto
Journal:  Virchows Arch       Date:  2011-09-17       Impact factor: 4.064

5.  Disseminated carcinoma ex pleomorphic adenoma in an adolescent confirmed by application of PLAG1 immunohistochemistry and FISH for PLAG1 rearrangement.

Authors:  Armita Bahrami; James D Dalton; Shivakumar Bangalore; Charlene Henry; Jeffrey F Krane; Fariba Navid; David W Ellison
Journal:  Head Neck Pathol       Date:  2012-09

6.  Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins.

Authors:  C Brenner; P Garrison; J Gilmour; D Peisach; D Ringe; G A Petsko; J M Lowenstein
Journal:  Nat Struct Biol       Date:  1997-03

Review 7.  Salivary gland-like tumours of the breast: surgical and molecular pathology.

Authors:  M Pia-Foschini; J S Reis-Filho; V Eusebi; S R Lakhani
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

8.  The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8.

Authors:  R M Gemmill; J D West; F Boldog; N Tanaka; L J Robinson; D I Smith; F Li; H A Drabkin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

Review 9.  Translocations in epithelial cancers.

Authors:  J Chad Brenner; Arul M Chinnaiyan
Journal:  Biochim Biophys Acta       Date:  2009-05-04

10.  Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands.

Authors:  H Nagel; R Laskawi; H Eiffert; T Schlott
Journal:  Mol Pathol       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.